Trends in surgery for Crohn's disease in the era of infliximab.
about
Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBDImaging of intestinal fibrosis: current challenges and future methodsMedical Therapy of Fibrostenotic Crohn's DiseaseImpact of medical therapies on inflammatory bowel disease complication rateCharacterizing intestinal inflammation and fibrosis in Crohn's disease by photoacoustic imaging: feasibility study.Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.Circulating fibrocytes and Crohn's disease.Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a "Top-Down" approach to intestinal fibrosis in miceRole of wireless capsule endoscopy in the follow-up of inflammatory bowel disease.Select a suitable treatment strategy for Crohn's disease: step-up or top-down.Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea.Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's diseaseSurgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004)Early surgery in Crohn's disease a benefit in selected cases.Infliximab extends the duration until the first surgery in patients with Crohn's disease.Surgery for Crohn's disease in the era of biologicals: a reduced need or delayed verdict?Surgery for Crohn's disease and anti-TNF agents: the changing scenario.An update on medical management on Crohn's disease.Inflammatory bowel disease meta-evidence and its challenges: is it time to restructure surgical research?Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg.Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.Hospitalizations for Crohn's Disease - United States, 2003-2013.Preoperative Nutritional Conditioning of Crohn's Patients-Systematic Review of Current Evidence and Practice.The future developments in nutrition.Short-term outcomes of laparoscopic surgery for Crohn's disease patients treated with anti-tumor necrosis factor alpha agents.Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblastsComplications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.Laparoscopic surgery for complex and recurrent Crohn's disease.Recent developments in the surgical management of perianal fistula for Crohn's disease.National trends in intestinal resection for Crohn's disease in the post-biologic era.Fibrocytes, inflammation, and fibrosis in Crohn's disease: another piece of the puzzle.TNFSF15 is an independent predictor for the development of Crohn's disease-related complications in Koreans.Cost-utility analysis of biologic treatments for moderate-to-severe Crohn's disease.Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study.Frequency of equivocation in surgical meta-evidence: a review of systematic reviews within IBD literature.Increased ultraviolet light exposure is associated with reduced risk of inpatient surgery among patients with Crohn's disease.Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.The association between intensified medical treatment, time to surgery and ileocolic specimen length in Crohn's disease.The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn's disease: national UK population-based study 1989-2010.
P2860
Q26740540-5255C65E-987D-4A0A-ACE5-E5312BB21DFBQ26740545-468FF916-2FE8-49FF-9A9A-9F798B479643Q26777724-75C90DE5-D5BC-402F-B355-B63DAACC6178Q26995479-EB16ED6B-2EC8-4707-A1A2-441769E63AB4Q30378404-ABA48FFB-E7C7-42DB-A4A1-45AE724A178FQ34167771-CF613AAA-24EE-448D-A887-DCB30B3CD6B1Q34387011-41740F97-F342-4CC3-B490-CB86D02DA79BQ35510528-D62D8326-6EB7-4239-901E-5130DBECB76FQ35709756-F5E4F69A-4D7B-4120-8457-F44FFD24AC57Q35721537-C55452A7-3D33-43A3-A86A-0A6F9A8619DDQ36043775-BD30BF2C-C523-4032-B07A-E168EE2FFA19Q36055027-AC7276F6-4F19-42F1-8479-F24A303E3A11Q36611183-AE405FCC-D1E0-432A-AF01-760146A3BB48Q37089435-B344CCE9-8807-4D01-9966-A23FBE939804Q37382433-225184AE-A5DF-4A0D-808C-6336FB8B49D5Q38033153-8AB559D2-34C7-4DDB-B8C2-9EC391A61013Q38155663-5075361E-5B57-48FA-8BD6-CB8CDCC2C817Q38270674-60455D3B-0D65-4594-B3D0-273D1171AA03Q38302725-766A1F75-0BF3-4BE8-AC4D-D0EC387A4DEAQ38692263-72C17790-8A46-4785-89F3-D2688E0AAB66Q38820319-4BD25299-0377-401E-9FCA-A0AD5D780EBDQ38838414-5A411765-88D6-4EFE-BA7A-47B0183C0717Q39354624-0919D8E6-5998-4522-9355-81A96445C422Q39594253-F83BE952-CC03-4A9C-83E5-CB3899C4CB1FQ39636883-7D299A51-4E93-474D-8639-E1D5EA2CC01CQ42044193-1CF039EA-662E-47AD-91BD-76A19D4FD7DAQ42224687-64BFF716-2C85-499F-89DE-379727CC0CCBQ42362116-006D80DF-CEE1-4498-A400-D41EDE8B4627Q42934166-7A1BEC74-C4FA-4014-A507-36C640E80BEEQ44156732-FC5F03DA-E4F5-4043-9FBD-BCE88298A1B0Q44989287-F86F98F7-CA78-419A-B2FC-BA436564F54AQ45332811-54AE99A1-5025-4A0B-9452-4737E042286EQ47862084-228FBA18-EF17-4DC9-9BEB-462E795A2600Q48017823-F21FE2E8-EF61-43C8-B28E-FBB74C6883F1Q48091969-6A43B446-DD13-46EB-BDE6-DC91AF8A9138Q48150632-9F27494C-A390-4243-BCCD-72725E99C6C9Q48564541-D5A39D5A-3AF5-4219-A6B7-A0BFCBFDF1DEQ51017516-ED943874-B6BF-4354-A526-39108D05A429Q51046939-78F5C8E0-93B3-4CC0-9AD2-34F295AE1DEBQ52840376-D3C72959-1082-42D5-808A-9262B85797F8
P2860
Trends in surgery for Crohn's disease in the era of infliximab.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Trends in surgery for Crohn's disease in the era of infliximab.
@en
Trends in surgery for Crohn's disease in the era of infliximab.
@nl
type
label
Trends in surgery for Crohn's disease in the era of infliximab.
@en
Trends in surgery for Crohn's disease in the era of infliximab.
@nl
prefLabel
Trends in surgery for Crohn's disease in the era of infliximab.
@en
Trends in surgery for Crohn's disease in the era of infliximab.
@nl
P1433
P1476
Trends in surgery for Crohn's disease in the era of infliximab.
@en
P2093
Douglas W Jones
Samuel R G Finlayson
P304
P356
10.1097/SLA.0B013E3181E61DF5
P407
P577
2010-08-01T00:00:00Z